U.S. trial tests ivonescimab for advanced biliary tract cancer
A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard chemoimmunotherapy in U.S. patients with advanced ...
A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard chemoimmunotherapy in U.S. patients with advanced ...
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity against ultra-high-risk ...
The Alliance for Clinical Trials in Oncology marks Breast Cancer Awareness Month with eight active trials spanning treatment de-escalation, survivorship ...
A study of more than 400,000 U.S. adults published in PLOS Medicine found that total ultra-processed food intake was not ...
A five-year, $3.4 million National Cancer Institute grant will help a Boston University-led consortium translate the Lung Pre-Cancer Atlas into ...
The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
A five-year evaluation of UAB's RACE21 program shows that sustained, mentored undergraduate cancer research can produce a 98.5 percent graduation ...
The National Comprehensive Cancer Network's two-day Oncology Policy Summit in Washington, D.C. united leaders from the NCI, CDC, and advocacy ...
A new ecological study of more than 1,300 US counties finds that higher levels of reported loneliness are significantly associated ...
A new analysis of 18 National Cancer Institute funded pilot projects reveals that most measurement tools for the 2024 National ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine